Day: August 5, 2025

Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin and Apelin receptors, aiming to transform treatment landscape Designed to address emerging areas of patient need, including long-term weight management, co-morbid metabolic disorders, and muscle preservation during weight lossTokyo, Japan and Cambridge, UK, 6 August 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces the launch of a broad new pipeline strategically focused on advancing next-generation therapies for obesity and associated metabolic disorders. Independent to the productive drug discovery collaborations with Pfizer and Eli Lilly, Nxera has established, expanded and accelerated drug discovery efforts of its own proprietary pipeline...

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQB: GALKF) (“Galantas” or the “Company”) is pleased to report the results of its Annual and Special Meeting held on August 5, 2025. All resolutions were passed by shareholders. Shareholders voted in favour of the election of all director nominees for the ensuing year: Mario Stifano, James B. Clancy, Róisín Magee, David Cather, and Brent Omland. Shareholders also voted in favour of (i) appointing Clearhouse LLP, Chartered Professional Accountants as the auditors of the Company for the ensuing year and authorizing the Board of Directors to fix their remuneration; (ii) ratifying and confirming the “rolling” stock option plan of the Company as more particularly set out in its Management Information Circular; and in accordance with the announcement...

Ongoing momentum in FAST channel sales drives revenue growth and profitabilityOrganic growth of 12.5% year-over-year in Broadcast and Recurring Commercial Music Revenues; Revenues increased 7.4% to $95.6 million in the first quarter of 2026 from $89.1 million in the first quarter of 2025; Adjusted EBITDA(1) rose 8.3% to $33.7 million in the first quarter of 2026 from $31.1 million in the same period in 2025. Adjusted EBITDA(1) by segment was $24.4 million or 39.8% of revenues for Broadcasting and Commercial Music, $11.0 million or 32.3% of revenues for Radio, and $(1.8) million for Corporate; Net income increased to $16.8 million, or $0.24 per share, in the first quarter of 2026 compared to $7.3 million, or $0.11 per share, in the first quarter of 2025; Adjusted Net income(1) grew 53.0% to $21.3 million, or $0.31 per share, in the first...

TOKYO, Aug. 05, 2025 (GLOBE NEWSWIRE) — CTW Cayman (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free-to-play games inspired by popular Japanese animations, today announced the pricing of the initial public offering (the “Offering”) of 2,400,000 Class A ordinary shares at a public offering price of $5.00 per share. The ordinary shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on August 6, 2025, under the ticker symbol “CTW”. The Company expects to receive aggregate gross proceeds of $12.0 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a...